Nosocomial infections caused by methicillin-resistant staphylococci (MRSA) pose a serious problem in many countries. This study aimed to determine the antibacterial susceptibility patterns of methicillin sensitive and resistant Staphylococcus aureus isolates from the hospitalized patients. were determined by E test method. Cross-resistances of MRSA isolates (137+19) to the other tested antibiotics were also determined. S.aureus with high frequencies were isolated from the blood, sputum and deep wound samples. All of 200 MSSA isolates were sensitive to oxacillin, vancomycin, tecoplanin, rifampin, linezolid, quinupristin/dalfopristin, mupirocin and fusidic acid. A gradient of reduced susceptibility of MSSA to cephalexin, co-trimoxazole, ciprofloxacin, clindamycin, tetracycline, erythromycin and gentamicin were evident. MRSA isolates were sensitive to vancomycin, tecoplanin, linezolid, quinupristin/dalfopristin, mupirocin and fusidic acid, while reduced susceptibility of them to rifampin, co-trimoxazole, clindamycin, cephalexin, tetracycline, ciprofloxacin, erythromycin and gentamicin were observed. MRSA isolates exhibited a high range of cross-resistance to the eight tested antibiotics. Overall, co-trimoxazole, ciprofloxacin, clindamycin, tetracycline, erythromycin and gentamicin showed low activity against MSSA and MRSA isolates which may indicate they are not suitable to be used in clinical practices. To preserve the effectiveness of antibiotics, rational prescription and concomitant application of preventive measures against the spread of MRSA are recommended.
INTRODUCTION
Staphylococcus aureus is a major nosocomial pathogen that causes a range of diseases such as endocarditis, osteomyelitis, toxic-shock syndrome, food poisoning, carbuncles, and boils (21) . With the discovery of β-lactam antibiotics in the late 1930s, remarkable hope for the treatment of infectious disease appeared. However, in the early 1950s, acquisition and spread of β-lactamase producing plasmids thwarted the effectiveness of penicillin for treating S. aureus Methicillin resistant and sensitive S. aureus infections. In 1959, methicillin, the synthetic penicillin, was introduced while by 1960, methicillin-resistant S. aureus strains were identified. It was the direct result of S. aureus acquiring the mecA gene, which encodes for an altered penicillin binding protein gene (PBP2a) (2) . By the early 1960s, European hospitals were reporting outbreaks of MRSA infections, and subsequently MRSA clones spread to healthcare institutions around the world (27) . In the United States, MRSA is responsible for approximately 25% of nosocomial infections, and reports of community acquired MRSA infections are increasing (28) . The multidrug resistant phenotypes of MRSA strains and their intrinsic β-lactam resistance make them difficult and costly to treat (5, 24) . In some medical institutions such as New York city hospitals, MRSA accounts for approximately 29% of the nosocomial infections and 50% of the associated deaths (25) . Similarly, the high prevalence of MRSA in Shiraz and other parts of Iran have been reported previously (8, 12, 20) . Controlling MRSA remains a primary focus of the most hospital infection control programs (3). Unfortunately, the clinical management of the MRSA infected patients has been complicated by the increasing proportion of infections, a problem that was initially limited to the hospital-acquired strains but has now extended to the community-associated strains (24, 28) . Attributable mortality rates for S. aureus bacteremia (SAB) in the developed world have risen up to 30% (7, 10, 15) , and the costs of treating nosocomial infections, screening for MRSA carriage, and changes in prescribing practice to include the coverage for MRSA are considerable. The availability of overthe-counter antibiotics in many developing countries is likely to be a major driver of drug resistance.
This study seeks to determine the prevalence of MRSA, MSSA and to analyze qualitative and quantitative aspects of antibiotics susceptibility patterns of the isolated bacteria in hospitalized patients. Furthermore, the cross-resistance of MRSA isolates to the tested antibiotics will be determined.
Availability of such data have clinical implications for selecting suitable empirical antibiotic therapy, reducing length of stay in the hospital, as well as reducing the mortality/morbidity rates in the patients with infectious diseases. Furthermore, findings of the above regional studies could be comparatively developed to other parts of the world.
MATERIALS AND METHODS

Isolation of staphylococci
Totally 356 consecutive non-duplicate Staphylococcus aureus were isolated from the blood, urine, sputum, deep wound, nasal washing, skin lesion, nose swab, abscess, CSF, 
Cross-resistance profile
To carefully characterize the patterns of antibiotic resistance of MRSA, cross-resistance of the isolates to 8
antibiotics with reduced activities were calculated by SPSS version 11.5 software.
RESULTS
S. aureus with high frequencies were isolated from the blood, sputum and deep wound samples, while low frequencies of this bacterium were isolated from ascetic fluid and perinea samples ( Table 1 ). All of the 200 MSSA isolates were found sensitive to eight antibiotics and a gradient of reduced susceptibility of the MSSA to seven antibiotics were noticed (Table 2) . Based on MICs determination, all the 156 MRSA were sensitive to vancomycin, tecoplanin, linezolid, quinupristin/dalfopristin, mupirocin and fusidic acid and a reduced gradient of susceptibility of MRSA to the rest of antibiotics were observed (Table 2 ). To interpret antibiotic resistance patterns of MRSA more precisely, cross-resistance of these isolates to the eight antibiotics with reduced anti-MRSA activities were calculated and presented in Table 3 .
MRSA isolates showed high range of cross-resistance to the eight tested antibiotics including co-trimoxazole (93-100 %), Figure 1 . aureus with high frequency was isolated from the blood samples (30.6 %), of which 50% were MRSA, followed by sputum and deep wound samples with 14 % and 13.5 %, respectively. The high incidence of S.aureus bacteremia (SAB), mostly driven by community acquired (CA) infections was also previously reported (7, 10, 14, 15) . Studies 
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